This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Dec 9;138(23):2305-2307.

doi: 10.1182/blood.2021013285.

The more complex, the worse outcome in CLL

Richard Rosenquist¹

Affiliations

PMID: 34882215
DOI: 10.1182/blood.2021013285

Free article

Editorial

The more complex, the worse outcome in CLL

Richard Rosenquist. Blood. 2021.

Free article

. 2021 Dec 9;138(23):2305-2307.

doi: 10.1182/blood.2021013285.

Author

Richard Rosenquist¹

Affiliation

¹ Karolinska Institutet.

PMID: 34882215
DOI: 10.1182/blood.2021013285

Erratum in

Rosenquist R. The more complex, the worse outcome in CLL. Blood. 2021;138(23):2305-2307.
[No authors listed] [No authors listed] Blood. 2022 Feb 24;139(8):1256. doi: 10.1182/blood.2021015221. Blood. 2022. PMID: 35201325 No abstract available.

No abstract available

PubMed Disclaimer

Comment on

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Kittai AS, Miller C, Goldstein D, Huang Y, Abruzzo LV, Beckwith K, Bhat SA, Bond DA, Grever MR, Heerema NA, Rogers KA, Ruppert AS, Byrd JC, Woyach JA. Kittai AS, et al. Blood. 2021 Dec 9;138(23):2372-2382. doi: 10.1182/blood.2020010536. Blood. 2021. PMID: 34314481

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems